UTHR Financial Facts
Continuing operations (in dollars per share): 1.62Discontinued operations (in dollars per share): 0
See Full Income Statement
Total liabilities and stockholders' equity: 1.63B
Mortgage payable-noncurrent: 70.34M
See Full Balance Sheet
Earnings History for United Therapeutics Corp. (UTHR)
|
Expand Research on UTHR
| Next EPS Date | 2/14/13 | EPS Growth Rate | +57.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +14.2% | Revenue Growth Rate | +19.6% |
| Average % Move 1-Wk after EPS | +6.2% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/28/10  |
 |
Q310 | $0.66 | $0.54 | +$0.12 | N/A | N/A | N/A / N/A | N/A | +24.1% | Details |
| 7/26/12 |
|
Q212 | $1.34 | $1.12 | +$0.22 | $225.6M | $213.33M | N/A / N/A | N/A | +36.8% | Details |
| 11/1/12 | Q312 | $1.52 | $1.26 | +$0.26 | $242.5M | $227.63M | $1.26 / $229M | N/A | +50.9% | Details | |
| 2/26/13 |
|
Q412 | $1.65 | $1.25 | +$0.40 | $243.82M | $233.41M | N/A / N/A | = | +19.5% | Details |
| 4/25/13 |
|
Q113 | $1.24 | $1.47 | -$0.23 | $245.1M | $241.14M | N/A / N/A | = | +9% | Details |
| 4/26/12 |
|
Q112 | $1.32 | $0.93 | +$0.39 | $204.2M | $203.91M | N/A / N/A | N/A | +59.8% | Details |
| 7/28/11 |
|
Q211 | $1.49 | $0.53 | +$0.96 | $183.75M | $180.84M | N/A / N/A | N/A | +26.1% | Details |
| 2/15/11 |
|
Q410 | $1.27 | $0.62 | +$0.65 | $166.5M | $174.87M | N/A / N/A | N/A | 0% | Details |
